Biotechnology

New patent for the drug Braintree Labs SUTAB – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in New patent for the Braintree Labs drug SUTAB

Annual Drug Patent Expiration for SUTAB
Annual Drug Patent Expiration for SUTAB

Sutab is a drug marketed by Braintree Labs and is included in one NDA. It is available from a single supplier. There are three patents protecting this drug.

SUTAB drug price trends.

The generic ingredient in SUTAB is magnesium sulfate; potassium chloride; sodium sulfate. One registered supplier for this compound. Additional details are available on the magnesium sulfate; potassium chloride; sodium sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patent for the Braintree Labs drug SUTAB

[ad_2]

Source link

Related Articles

Back to top button